Skip to content

Lucid Diagnostics Inc.

LUCD· NasdaqCore metricsCIK 1799011

Surgical & medical instruments & apparatus142 peers

Last sale
Nov 12, 2026 · +7.83%
Market cap
$86.41M
206.98M shares
Filings
283
$1.20M
Q3 2026+8.3% FY25 yoy
-$6.68M
Q3 2026N/M FY25 yoy
-$12.28M
Q3 2026N/M FY25 yoy
-$39.20M
Q3 2026derivedN/M FY25 yoy
-$0.10
Q3 2025N/M FY24 yoy
$47.33M
Q3 2025+18.3% FY24 yoy
$86.41M
—
15.9×
14.6×
-59.98%
—

Twelve months to Sep 30, 2026 · derived

Price

$0.417559.86%$0.6225past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$4.71MFY 2025
$4.71M0FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$4,706,000reported
FY 20242024-12-31$4,346,000reported
FY 20232023-12-31$2,428,000reported
FY 20222022-12-31$377,000reported
FY 20212021-12-31$500,000reported

Surgical & medical instruments & apparatus

Lucid Diagnostics Inc. is the 94th largest of the 143 covered companies the SEC files under this code, by revenue. SIC 3841

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Lucid Diagnostics Inc. · CIK 1799011 · Engraved from SEC EDGAR